Kainos Group plc Director/PDMR Shareholding (2338X)
August 08 2018 - 9:20AM
UK Regulatory
TIDMKNOS
RNS Number : 2338X
Kainos Group plc
08 August 2018
08 August 2018
Kainos Group plc
("Kainos" or the "Company)
Director / PDMR Dealing
The Company was notified on the 08 August 2018, that Brendan
Mooney, CEO, exercised his 2015 PSP options over 98,921 ordinary
shares of GBP0.005 in the Company ("Ordinary Shares"), at an
exercise price of GBP0.005 per Ordinary Share.
Brendan Mooney retained the Ordinary Shares on exercise.
Following this notification, Brendan Mooney and his Person
Closely Associated (PCA) have a reportable shareholding of
14,205,941 Ordinary Shares in the issued share capital of the
Company, constituting 11.88% of the issued share capital of the
Company.
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name Brendan Mooney
------------------------------ -------------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------
a. Position/status CEO/PDMR
------------------------------ -------------------------------------------
b. Initial notification Initial notification
/Amendment
------------------------------ -------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------
a. Name Kainos Group plc
------------------------------ -------------------------------------------
b. LEI 213800H2PQMIF3OVZY47
------------------------------ -------------------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------------
a. Description of Ordinary Shares of GBP0.005 each
the
Financial instrument/
type of instrument ISIN: GB00BZ0D6727
Identification
code
------------------------------ -------------------------------------------
b. Nature of the transaction Exercise of 2015 PSP Options and retention
of shares
------------------------------ -------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
GBP0.005 98,921
----------
------------------------------ -------------------------------------------
d. Aggregated information
* Aggregated volume N/A
* Price
------------------------------ -------------------------------------------
e. Date of the transaction 08 August 2018
------------------------------ -------------------------------------------
f. Place of the transaction Outside a trading venue
------------------------------ -------------------------------------------
Classification: Additional Regulated Information
Ends
For further information, please contact:
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Investec Bank plc 44 20 7597 5970
Patrick Robb / Sebastian Lawrence
Canaccord Genuity +44 20 7523 4606
Simon Bridges / Emma Gabriel
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Harry Staight
About Kainos
Kainos Group plc is a UK-based provider of Digital Services and
Digital Platforms.
The Group's Digital Services include full lifecycle development
and support of customised Digital Services for government and
commercial customers. Kainos is also the leading European partner
for Workday Inc. ('Workday') responsible for implementing Workday's
innovative Software-as-a-Service (SaaS) platform for enterprise
and, now, government customers.
The Group's Digital Platforms comprise specialised digital
products in the mobile healthcare and automated testing arenas.
Smart is an automated testing platform for Workday customers;
Evolve Electronic Medical Records ('EMR') is the market leading
product for the digitisation of patient notes in the Acute sector
of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based
integrated care platform for the NHS and international healthcare
providers; and Smart is an automated testing platform for Workday
customers.
Kainos has over 1,150 people across eleven offices in Europe and
the USA, working interchangeably across its Services and Platforms
divisions.
Kainos is listed on the London Stock Exchange (LSE: KNOS). For
further information, please visit www.kainos.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFKFDDNBKDFFK
(END) Dow Jones Newswires
August 08, 2018 09:20 ET (13:20 GMT)
Kainos (LSE:KNOS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kainos (LSE:KNOS)
Historical Stock Chart
From Jul 2023 to Jul 2024